No photo of Olivia Monteiro

View Scopus Profile

Monteiro, Olivia

Dr

  • 22 Citations
  • 2 h-Index
20172018
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Olivia Monteiro is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles
Huntington Disease Medicine & Life Sciences
Metformin Medicine & Life Sciences
GABA-A Receptors Medicine & Life Sciences
Pharmacology Medicine & Life Sciences
Neurons Medicine & Life Sciences
Peptides Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Human Immunodeficiency Virus Proteins Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2017 2018

  • 22 Citations
  • 2 h-Index
  • 3 Article
10 Citations (Scopus)
96 Downloads (Pure)

Metformin reverses early cortical network dysfunction and behavior changes in Huntington's disease

Arnoux, I., Willam, M., Griesche, N., Krummeich, J., Watari, H., Offermann, N., Weber, S., Narayan Dey, P., Chen, C., Monteiro, O., Buettner, S., Meyer, K., Bano, D., Radyushkin, K., Langston, R., Lambert, J. J., Wanker, E., Methner, A., Krauss, S., Schweiger, S. & 1 others, Stroh, A., 4 Sep 2018, In : eLife. 7, p. 1-32 32 p., e38744.

Research output: Contribution to journal › Article

Open Access
File
Metformin
Huntington Disease
Animal Behavior
Aberrations
Visual Cortex
119 Downloads (Pure)

Pharmacological disruption of the MID1/α4 interaction reduces mutant Huntingtin levels in primary neuronal cultures

Monteiro, O., Chen, C., Bingham, R., Argyrou, A., Buxton, R., Jönsson, C. P., Jones, E., Bridges, A., Gatfield, K., Krauß, S., Lambert, J., Langston, R., Schweiger, S. & Uings, I., 23 Apr 2018, In : Neuroscience Letters. 673, p. 44-50 7 p.

Research output: Contribution to journal › Article

Open Access
File
Huntington Disease
Pharmacology
Peptides
Human Immunodeficiency Virus Proteins
S 6
12 Citations (Scopus)
91 Downloads (Pure)

Selective inhibition of extra-synaptic α5-GABAA receptors by S44819, a new therapeutic agent

Etherington, L-A., Mihalik, B., Pálvölgyi, A., Ling, I., Pallagi, K., Kertész, S., Varga, P., Gunn, B. G., Brown, A. R., Livesey, M. R., Monteiro, O., Belelli, D., Barkóczy, J., Spedding, M., Gacsályi, I., Antoni, F. A. & Lambert, J. J., Oct 2017, In : Neuropharmacology. 125, p. 353-364 12 p.

Research output: Contribution to journal › Article

Open Access
File
GABA-A Receptors
Benzodiazepines
gamma-Aminobutyric Acid
Therapeutics
Central Nervous System